drugset / Trial / NCT01293955

Assessment of Protective Effect of JOINS on Cartilage in Knee Osteoarthritis

NCT01293955 ↗

Phase 4 Completed 76 enrolled SK Chemicals Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

* A Pilot study * Randomized and Double-blinded * Placebo controlled * In 2 parallel group (JOINS 200mg:Placebo = 1:1) * Overall 24 months treatment (JOINS:Placebo comparison up to 12 months, Additional follow-up assessment up to 24 months) * Provide rescue medicine throughout whole clinical trial period.

Timeline

Start
2010-08
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject JOINS Unknown 200 mg —

Indications